.png){kind=logo}
Inside the assembly lines of molecular diagnostics manufacturers, the equipment that produces cartridges used to test tuberculosis, COVID, and cancer runs under one of the most surveilled quality regimes in industrial manufacturing. Until recently, much of that surveillance happened the slow way. Test data trickled into databases only after manual uploads. Statistical investigations ran on schedules that felt antique next to the conveyor belts they were meant to oversee. A defect caught a shift late was still a defect caught late.
That asymmetry between how the machines move and how the data moves is finally closing. A wave of analytics engineers is wiring inline sensors, real-time data pipelines, and AI-driven anomaly detection into the production floors of FDA-regulated medical-device makers. The work happens out of sight of the marketing copy that usually accompanies “AI in manufacturing,” and it doesn’t look like a chatbot or a generative model. It looks like a sensor on a fluidics line streaming a signal to a cloud platform that flags a deviation while the lot is still in progress.
Suchitra Venkatesan is one of the engineers driving that shift. As a production data scientist at a leading MedTech company, she leads an internal real-time analytics platform that pulls test data across multiple layers, provides intelligent line-related analytics and pushes it into validated dashboards. The platform has produced one of the more concrete operational metrics in this corner of the industry. Product quality test data is now able to reach database in a near real-time basis, circumventing the need for manual data uploads. In a production environment where every lot represents tests destined for hospitals and clinical labs, that is the difference between catching a defect before shipment and not.
The architecture behind the change is not exotic. Ms.Venkatesan’s workflow will potentially replace an age-old process that depends on humans uploading test data into a database with one that draws data directly from instruments on the production floor and pushes it through a cloud platform into PowerBI dashboards. The signal layer combines system data from instruments with quality metrics. The presentation layer potentially surfaces anomalies while a lot is still moving. The transition matters less for any single technical component than for what it changes about the production floor’s decision tempo.
What changed first was the cadence of visibility. Most healthcare manufacturers report on a daily or end-of-shift basis. Ms.Venkatesan’s data-driven analytics layer brought that down to the hour, giving operations leadership a near-live read on output and equipment behavior. Patterns that daily aggregation had quietly hidden, such as equipment drift, supply pacing irregularities, and downstream test variability, became visible inside the shift in which they happened. Severaldepartments inside the organization now rely on the data foundation she helped lay.
The methodological roots run deeper than the current project. In 2019, Ms.Venkatesan authored a paper in IET Electric Power Applications on the use of an intelligent digital twin to monitor and predict the health of electric vehicle motors. The paper has accumulated more than two hundred citations and was awarded the IET Electric Power Applications Premium Award in 2021, the journal’s best-paper honor. The framework it laid out, sensor telemetry feeding a predictive model whose signal lets operators intervene before a failure rather than after one, is the same conceptual scaffolding she now applies to the equipment that produces molecular diagnostic tests.
“Using intelligent digital twins isn’t explored very well in healthcare domain,” Ms.Venkatesan has written. “Predictive diagnostics can greatly reduce downtime and production latency. With a technology similar to the one described in my IET paper, critical life-saving machines can be monitored remotely and saved from inadvertent failure or stoppage before it even occurs.”Most coverage of AI in manufacturing skips the regulatory layer. Healthcare manufacturersoperate under the US Food and Drug Administration’s Quality System Regulation, with audit trails, validation protocols, and documented decision logic for any signal that influences a quality call. Building a real-time AI pipeline for an unregulated factory is one thing. Building one whose every alert must be defensible to a regulator is something else. Engineers who came to work with data the way Ms.Venkatesan did, through instrumentation engineering and sensor and control systems, tend to be the ones who can hold both halves in their head at once. Her two graduate degrees, one in sensors and control systems and one in business analytics, sit on either side of the gap that most AI projects in regulated manufacturing must cross.
The wider market has been catching up to the kind of work she has been doing. Real-time data pipelines, intelligent digital twins, and AI-driven predictive maintenance are converging into a standard toolkit for what some industry observers now call smart-factory healthcare. The framing is grand. The day-to-day work, as Ms.Venkatesan’s project shows, is more specific. It looks like cutting manual & redundant time out of a quality investigation, replacing a manual upload with a cloud-based data stream, and giving operations theability to read the factory floor an hour at a time instead of a day at a time. That is what the next phase of AI in healthcare manufacturing looks like.
